Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAT1 | P18440 | 5/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 0.72 |
| ▸ | PIM1 | P11309 | 5/20 | 0.68 |
| ▸ | MYC | P01106 | 1/20 | 0.63 |
| ▸ | MAX | P61244 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.62 |
| ▸ | GSK3B | P49841 | 1/20 | 0.62 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.58 |
| ▸ | ALPL | P05186 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9573277 | 1.00 | NAT1 (1.00) | NAT1TTRPIM1MYCMAX | |
| SCHEMBL32672283 | 0.85 | NAT1 (0.74) | NAT1TTRPIM1MYCMAX | |
| SCHEMBL13724876 | 0.84 | TTR (1.00) | NAT1TTRPIM1GSK3BMEN1 | |
| SCHEMBL7464188 | 0.84 | TTR (1.00) | NAT1TTRPIM1GSK3BMEN1 | |
| SCHEMBL15091770 | 0.84 | TTR (1.00) | NAT1TTRPIM1GSK3BMEN1 | |
| SCHEMBL13499564 | 0.83 | NAT1 (0.70) | NAT1PIM1CA2EPHX1PDE4B | |
| SCHEMBL8177171 | 0.82 | NAT1 (0.70) | NAT1TTRPIM1MYCMAX | |
| SCHEMBL15304598 | 0.82 | NAT1 (0.70) | NAT1PIM1MYCMAXCA2 | |
| SCHEMBL14226382 | 0.82 | NAT1 (0.69) | NAT1PIM1CA2GSK3BMEN1 | |
| SCHEMBL18103046 | 0.82 | GSK3B (0.73) | NAT1TTRPIM1MYCMAX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5306224-A | — | — | None | — | — | JP | disclosed |
| EP-2541329-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | Hodogaya Chemical Co., Ltd. (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| US-7872027-B2 | Low molecular weight Myc-max inhibitors | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2011-01-18 | — | — | US | disclosed |
| JP-H05306224-A | DOPAMINE BETA-HYDROXYLASE INHIBITOR | WAKAMOTO PHARMACEUT CO LTD | 1993-11-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | NPY1R, HCRTR1, CCKAR | NAT1 1604/4885TTR 4779/4885PIM1 3705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.